Significance of Interleukin (IL)-15 in IgE Associated Eosinophilic Esophagitis (EoE)
Overview
Affiliations
Background And Aim: IgE-mediated immune responses contribute to the pathogenesis of eosinophilic esophagitis (EoE). Interleukin (IL)-4 is a well-established cytokine involved in B cell activation, immunoglobulin (Ig) E production and isotype class switching. Earlier reports indicated that IL-15, B cells and IgE are induced in EoE pathogenesis. Therefore, we hypothesized that induced IL-15 and IgE may have a significant correlation in promoting EoE pathogenesis.
Methods: Accordingly, we performed ELISA, qPCR, flowcytometric and immunostaining analyses to examine IgE, B cells, eosinophils and mast cells in the esophagus of IL-15 overexpressed mice following EoE induction.
Results: Herein, we show that IL-15 overexpressed mice indeed have induced baseline IL-4, B cells, eosinophils, mast cells and IgE levels in the blood and esophagus. Further, we observed that IL-15 overexpressed mice show induction of IgE, and accumulation of degranulated eosinophils and mast cells in allergen-induced experimental EoE. Notably, despite induced blood IgE, esophageal eosinophilia is not induced in intestinal fatty acid binding protein IL-15 overexpressed gene (Fabpi-IL-15) mice. Fabpi-IL-15 transgenic mice showed IgE in the blood and intestine and intestinal eosinophilia, but no esophageal eosinophilia at baseline and comparable eosinophils in the esophagus of saline and allergen challenged Fabpi-IL-15 mice. Similarly, allergen challenged gene-deficient mice show reduced IgE and esophageal eosinophilia in allergen-induced experimental EoE.
Conclusions: Taken together, we for the first time provide direct evidence that tissue-specific IL-15 induced IgE mediated responses, not systemic IgE is critical in promoting EoE pathogenesis.
From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis.
Barchi A, Mandarino F, Yacoub M, Albarello L, Massimino L, Savarino E Biomolecules. 2024; 14(9).
PMID: 39334846 PMC: 11429508. DOI: 10.3390/biom14091080.
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets.
Racca F, Pellegatta G, Cataldo G, Vespa E, Carlani E, Pelaia C Front Physiol. 2022; 12:815842.
PMID: 35095572 PMC: 8790151. DOI: 10.3389/fphys.2021.815842.
Upparahalli Venkateshaiah S, Rayapudi M, Kandikattu H, Yadavalli C, Mishra A Clin Immunol. 2021; 227:108752.
PMID: 33945873 PMC: 8215583. DOI: 10.1016/j.clim.2021.108752.
Tacrolimus (FK506) treatment protects allergen-, IL-5- and IL-13-induced mucosal eosinophilia.
Kandikattu H, Upparahalli Venkateshaiah S, Verma A, Mishra A Immunology. 2021; 163(2):220-235.
PMID: 33512727 PMC: 8114213. DOI: 10.1111/imm.13314.